TrialStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2023
[The combination of stereotactic radiotherapy with checkpoint inhibitors: results of the CHEERS phase II trial].
Tobias MohrPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.